Combination of FDG-PET and FMISO-PET as a treatment strategy for patients undergoing early-stage NSCLC stereotactic radiotherapy.

Shiro WatanabeTetsuya InoueShozo OkamotoKeiichi MagotaAyumi TakayanagiJun Sakakibara-KonishiNorio KatohKenji HirataOsamu ManabeTakuya ToyonagaYuji KugeHiroki ShiratoNagara TamakiTohru Shiga

Published in: EJNMMI research (2019)

The combination of FDG- and FMISO-PET can identify patients with a baseline risk of recurrence and indicate whether additional therapy might be performed to improve survival.

Keyphrases

pet ct
positron emission tomography
pet imaging
early stage
computed tomography
patients undergoing
small cell lung cancer
free survival
sentinel lymph node
bone marrow
mesenchymal stem cells
cell therapy
advanced non small cell lung cancer
replacement therapy
neoadjuvant chemotherapy